Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Fuji
Chinese Patent Office
Citi
Covington
Teva
Mallinckrodt
Boehringer Ingelheim

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PREDNISOLONE ACETATE

« Back to Dashboard

Clinical Trials for Prednisolone Acetate

Trial ID Title Status Sponsor Phase Summary
NCT00134992 A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers Completed Novartis Phase 4 The objective of this trial was to confirm the tolerability of prednisolone acetate 0.5% eye drops by testing the hypothesis that the ocular safety and tolerability of prednisolone acetate 0.5% eye drops are equivalent to vehicle. Thus healthy volunteers have been selected and have been treated by using a crossover design.
NCT00170729 A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery Completed Novartis Phase 4 The primary objective was to demonstrate that two days of treatment with 0.5% prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye.
NCT00198523 A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte Completed Bausch & Lomb Incorporated Phase 3 The purpose of this study is to demonstrate the bioequivalence of the combination test agent, prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte (prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate.
NCT00229918 PST/Laser v. Laser Alone for CSME Unknown status Edward Hines Jr. VA Hospital Phase 2 Prospective randomized clinical trial comparing Laser Alone v. Laser and posterior sub-tenon injection of triamcinolone acetonide for primary and refractory clinically significant macular edema.
NCT00238563 Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery Unknown status Stanford University N/A Determine efficacy of sub tenon kenalog injections for post-operative management of trabeculectomy procedures.
NCT00345046 A Comparison of Three Different Formulations of Prednisolone Acetate 1% Completed Indiana University School of Medicine Phase 4 Generic prednisolone acetate 1% is less effective than Pred Forte 1% or Econopred Plus 1%.
NCT00406042 The Role of Steroids Following Selective Laser Trabeculoplasty Completed West Virginia University N/A To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Prednisolone Acetate

Condition Name

Condition Name for Prednisolone Acetate
Intervention Trials
Cataract 6
Prostatic Neoplasms 3
Prostate Neoplasms 3
Prostate Cancer 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Prednisolone Acetate
Intervention Trials
Cataract 14
Prostatic Neoplasms 10
Inflammation 10
Uveitis 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Prednisolone Acetate

Trials by Country

Trials by Country for Prednisolone Acetate
Location Trials
United States 143
Japan 20
Brazil 13
United Kingdom 12
Canada 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Prednisolone Acetate
Location Trials
California 11
New York 10
Massachusetts 10
Texas 9
Florida 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Prednisolone Acetate

Clinical Trial Phase

Clinical Trial Phase for Prednisolone Acetate
Clinical Trial Phase Trials
Phase 4 18
Phase 3 16
Phase 2/Phase 3 4
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Prednisolone Acetate
Clinical Trial Phase Trials
Completed 26
Recruiting 11
Active, not recruiting 7
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Prednisolone Acetate

Sponsor Name

Sponsor Name for Prednisolone Acetate
Sponsor Trials
Janssen Research & Development, LLC 4
Federal University of São Paulo 3
Alcon Research 3
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Prednisolone Acetate
Sponsor Trials
Industry 35
Other 32
U.S. Fed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Citi
Farmers Insurance
Fuji
Dow
Cantor Fitzgerald
Deloitte
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.